Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Operating Leases (2019 - 2025)

Standard Biotools (LAB) has disclosed Operating Leases for 7 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 2.16% to $25.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2025, down 2.16% year-over-year, with the annual reading at $25.0 million for FY2025, 2.16% down from the prior year.
  • Operating Leases for Q4 2025 was $25.0 million at Standard Biotools, up from $22.0 million in the prior quarter.
  • The five-year high for Operating Leases was $42.0 million in Q2 2021, with the low at $22.0 million in Q3 2025.
  • Average Operating Leases over 5 years is $32.0 million, with a median of $31.7 million recorded in 2023.
  • The sharpest move saw Operating Leases rose 6.81% in 2022, then decreased 21.9% in 2025.
  • Over 5 years, Operating Leases stood at $37.5 million in 2021, then decreased by 9.23% to $34.1 million in 2022, then dropped by 10.88% to $30.4 million in 2023, then dropped by 15.75% to $25.6 million in 2024, then decreased by 2.16% to $25.0 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $25.0 million, $22.0 million, and $23.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.